Archive: 27/09/2015

Genetic screening of brain metastases could reveal new targets for treatment

Unravelling the genetic sequences of cancer that has spread to the brain could offer unexpected targets for effective treatment, according to new research presented to the 2015 European Cancer Congress [1] today (Sunday) ...

Sep 27, 2015

Everolimus improves progression-free survival for patients with advanced, nonfuctional neuroendocrine tumors

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced, nonfunctional neuroendocrine ...

Sep 27, 2015

page 2 from 2

«
»